 |
U.S. healthcare M&A deal value soared to nearly $50 billion in Q2 2013
- Merger and acquisition activity fell to 229 deals from 249 in the first quarter, but higher values on individual deals drove total dollar volume to near record levels at $49.9 billion.
- Several major mergers drove the higher deal dollar value, including Thermo Fisher Scientific’s takeover of Life Technologies Corp. for $13.6 billion and Valeant Pharmaceuticals’ purchase of Bausch & Lomb for $8.7 billion.
- Hospital mergers seized center stage with two of the top five deals during the quarter led by Tenet Healthcare Corp.’s takeover of Vanguard Health Systems for $4.3 billion.
- Providers led the pack in making deals in the second quarter, with hospitals and other provider groups announcing 106 transactions, nearly double its previous quarter’s total.
| Target |
Location |
Seller (if applicable) |
Bidder |
Industry |
Sub-sector |
Purchase price |
Deal announced |
| Life Technologies |
Carlsbad, Calif. |
- |
Thermo Fisher Scientific |
Medical devices |
Diagnostics |
$13,600 |
4/15/2013 |
| Bausch & Lomb |
Rochester, N.Y. |
-- |
Valeant Pharmaceuticals |
Pharmaceuticals |
Drugs and biologics |
$8,700 |
5/27/2013 |
| Warner Chilcott |
Rockaway, N.J. |
- |
Actavis |
Pharmaceuticals |
Drugs and biologics |
$8,500 |
5/20/2013 |
| Vanguard Health Systems |
Nashville |
- |
Tenet Healthcare Corp. |
Providers |
Hospitals, acute-care |
$4,300 |
6/24/2013 |
| Revera |
Ontario, Canada |
-- |
Health Care REIT |
Providers |
Senior housing |
$1,350 |
5/8/2013 |
Buy all the 2nd Qtr 2013 M&A data »
| Target |
Location |
Seller (if applicable) |
Bidder |
Industry |
Sub-sector |
Purchase price |
Deal announced |
| Vanguard Health Systems |
Nashville |
- |
Tenet Healthcare Corp. |
Providers |
Hospitals, acute care |
$4,300 |
6/24/2013 |
| PRA International |
Raleigh, N.C. |
Genstar Capital |
KKR |
Pharmaceuticals |
Contract research organization |
$1,300 |
6/24/2013 |
| Pearl Therapeutics |
Redwood City, Calif. |
- |
AstraZeneca |
Pharmaceuticals |
Drugs and biologics |
$1,150 |
6/10/2013 |
| Aragon Pharma |
San Diego |
- |
Johnson & Johnson |
Pharmaceuticals |
Drugs and biologics |
$650 |
6/17/2013 |
| OrthoRecon business |
Arlington, Texas |
Wright Medical Group |
MicroPort Medical B.V. |
Medical devices |
Medical implants |
$290 |
6/19/2013 |
Buy all the June 2013 M&A data »
| Target |
Location |
Seller (if applicable) |
Bidder |
Industry |
Sub-sector |
Purchase price |
Deal announced |
| Bausch + Lomb |
Rochester, N.Y. |
- |
Valeant Pharmaceuticals |
Pharmaceuticals |
Drugs and biologics |
$8,700 |
5/27/2013 |
| Warner Chilcott |
Rockaway, N.J. |
- |
Actavis |
Pharmaceuticals |
Drugs and biologics |
$8,500 |
5/20/2013 |
| Revera |
Ontario, Canada |
- |
Health Care REIT |
Providers |
Senior housing |
$1,350 |
5/8/2013 |
| Omthera Pharmaceuticals |
Princeton, N.J. |
- |
AstraZeneca |
Pharmaceuticals |
Drugs and biologics |
$443 |
5/28/2013 |
| AOP Orphan Pharmaceuticals |
Vienna, Austria |
- |
Elan Pharmaceuticals |
Pharmaceuticals |
Drugs and biologics |
$340 |
5/20/2013 |
Buy all the May 2013 M&A data »
| Target |
Location |
Seller (if applicable) |
Bidder |
Industry |
Sub-sector |
Purchase price |
Deal announced |
| Life Technologies |
Carlsbad, Calif. |
- |
Thermo Fisher Scientific |
Medical devices |
Diagnostics |
$13,600 |
4/15/2013 |
| Conceptus |
Mountain View, Calif. |
- |
Bayer HealthCare |
Pharmaceuticals |
Drugs and biologics |
$1,100 |
4/29/2013 |
| Managed Health Care Associates |
Florham Park, N.J. |
- |
Roper Industries |
Medical technology |
Imaging |
$1,000 |
4/17/2013 |
| St. Luke's Episcopal Health System |
Houston |
- |
Catholic Health Initiatives |
Providers |
Hospitals, acute care |
$1,000 |
4/19/2013 |
| Actient Holdings |
Lake Forest, Ill. |
GTCR (private equity firm) |
Auxilium Pharmaceuticals |
Pharmaceuticals |
Drugs and biologics |
$585 |
4/29/2013 |
Buy all the April 2013 M&A data »
This report series covers trends and analyzes recent activity in the U.S. healthcare mergers and acquisitions market. Activity among the provider, payer, vendor and pharmaceutical/biotechnology sectors of the healthcare industry is comprehensively covered.
Q: What is Healthcare M&A Watch?
A: Healthcare M&A Watch is a digital report produced on a quarterly basis that covers trending and analysis of U.S. mergers and acquisitions among providers, payers, vendors and pharma/life sciences sectors of the healthcare industry. You can purchase the quarterly report individually for $199.
Q: I have a paid ModernHealthcare.com subscription. Can I get the Healthcare M&A Watch for free?
A: Yes, if you are a Premium Web subscriber. Premium Web subscribers have access to all the By The Numbers PDFs and research from Modern Healthcare Insights that are uploaded to our Healthcare Business Data Center.
|
 |
 |

August 12, 2013
|
|
|
|
|
|
 |